Immune Pharmaceuticals Inc (fka IMNPQ)

[Letterpenny]

This explains why warrants were tossed out in the last SPAC arrangement. “Practitioners must also be cautioned that the use of a “double dummy” transaction with respect to a special purpose acquisition company, or “SPAC,” does not provide tax-free treatment on the exchange of SPAC warrants.”

Now we just need one more dummy deal done with ESHA. Then we merge at the end.